> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Committee to Look at Risk Communication Plan
- URL: https://www.fdaweb.com/committee-to-look-at-risk-communication-plan/
- Published: 2016-11-03T12:00:00.000Z
- Updated: 2026-09-14T21:45:12.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137250

The FDA Risk Communication Advisory Committee meets 11/7 to discuss and make recommendations on the agency’s draft Strategic Plan for Risk Communication and Health Literacy, intended to clarify how FDA can communicate the benefits and risks of regulated products to target audiences more effectively and thus promote better decision making. The [plan](http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/RiskCommunicationsAdvisoryCommittee/UCM526451.pdf?ref=fdaweb.com) includes a strategic framework, performance indicators, a performance monitoring plan, and a short-term implementation plan.

The strategic plan’s overarching outcome is “increased accessibility to actionable and accurate FDA communication and benefit/risk information.” Four contributing outcomes on which the overarching outcome depends are: 

- increased use of clear communication best practices and plain language in developing messages;
- increased use of more targeted messages and communications;
- improved efficiency of internal operations for writing and developing communications; and
- improved dissemination of FDA’s communication and information.

In addition to commenting on this plan, advisory committee members will hear presentations on some of the agency’s external communications. At its February meeting, the committee had recommended that FDA conduct an environmental scan of its risk communications. In advance of the November meeting, the agency is giving committee members a [report](http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/RiskCommunicationsAdvisoryCommittee/UCM526449.pdf?ref=fdaweb.com) on 128 external communications coming from CBER, CDER, CDRH, the Center for Tobacco Products, the Office of the Commissioner, and the Office of Regulatory Affairs.